Sitemap
June 02, 2024 Articles
Filter by Available Specialty
- ‘Practice-changing data’ support first-line immunotherapy combination in colorectal cancer
- ‘There may be a role’ for frontline lifileucel plus pembrolizumab in advanced melanoma
- ‘We have the technology’: Telehealth increases access to palliative care for cancer
- Bioventus reports revenue growth in first-quarter 2024 financial results
- Chemotherapy regimen improves survival in advanced esophageal cancer
- Childhood cancer survivor turned pediatric oncologist aims to ‘give hope’ to patients
- Early-life stressors, younger puberty predict teen substance use for girls
- Neoadjuvant immunotherapy ‘the new standard’ for resectable stage III melanoma
- Next step in diabetes care: Use CGM data to inform treatment decisions
- Once-monthly octreotide provides sustained acromegaly control with fewer injections
- Oral therapy cuts androstenedione levels for children with congenital adrenal hyperplasia
- Regimen confers ‘clinically meaningful’ PFS benefit in relapsed multiple myeloma
- Semaglutide may change perception, brain response to sweet tastes
- Single excess weight measurement ‘does not seal one’s fate’ for heart-related events
- Trastuzumab deruxtecan improves PFS in pretreated breast cancer
- With abundant psoriasis treatments available, research now aiming for higher goals
- Yari Mitchell has questions for Patricia Buehler, MD: Becoming an ophthalmic innovator